We are live on
!
Find out more
HCM
Horan Capital Management Portfolio holdings
AUM
$794M
1-Year Est. Return
30.86%
This Fund
S&P 500
This Quarter
Est. Return
+5.24%
1 Year Est. Return
+30.86%
3 Year Est. Return
+69.18%
5 Year Est. Return
+124.11%
10 Year Est. Return
–
AUM
$511M
AUM Growth
+$50M
(+11%)
Cap. Flow
+$33.4M
Cap. Flow
% of AUM
6.53%
Top 10 Holdings %
Top 10 Hldgs %
53.34%
Holding
76
New
19
Increased
11
Reduced
29
Closed
9
Avg Time Held
7.3
quarters
Top 10 Avg Time Held
6.2
quarters
Top 20 Avg Time Held
8.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$38M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$32.7M |
| 3 |
Apple
AAPL
|
+$22.7M |
| 4 |
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
|
+$12.3M |
| 5 |
Schwab US TIPS ETF
SCHP
|
+$10.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$8.93M |
| 2 |
Cisco
CSCO
|
+$5.91M |
| 3 |
Biogen
BIIB
|
+$2.5M |
| 4 |
Gilead Sciences
GILD
|
+$866K |
| 5 |
Johnson & Johnson
JNJ
|
+$310K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.9% |
| 2 | Consumer Discretionary | 17.55% |
| 3 | Healthcare | 15.55% |
| 4 | Technology | 12.92% |
| 5 | Communication Services | 11.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.79T
| $40.7M | 7.96% |
+478,300
| New | +$38M |
2018 Q2
0 quarters
|
|
|
2
Berkshire Hathaway Class B
BRK.B
$1.11T
| $31.3M | 6.12% |
+167,568
| New | +$32.7M |
2018 Q2
0 quarters
|
|
3
Alphabet (Google) Class C
GOOG
$4.27T
| $30.3M | 5.94% |
543,620
+2,600
| +0.5% | +$140K |
2013 Q2
20 quarters
|
|
4
Visa
V
$744B
| $29.7M | 5.8% |
223,895
-2,005
| -0.9% | -$258K |
2013 Q2
20 quarters
|
|
5
Meta Platforms (Facebook)
META
$1.94T
| $28.3M | 5.54% |
145,648
+16,264
| +13% | +$2.94M |
2017 Q1
5 quarters
|
|
6
Microsoft
MSFT
$4.04T
| $27.3M | 5.34% |
276,778
-2,938
| -1% | -$285K |
2013 Q2
20 quarters
|
|
7
TJX Companies
TJX
$156B
| $24.6M | 4.81% |
516,366
-2,098
| -0.4% | -$92.1K |
2017 Q3
3 quarters
|
|
|
8
Apple
AAPL
$4.98T
| $23.1M | 4.53% |
+500,104
| New | +$22.7M |
2018 Q2
0 quarters
|
|
|
9
Gilead Sciences
GILD
$183B
| $18.8M | 3.68% |
265,477
-12,264
| -4% | -$866K |
2016 Q1
9 quarters
|
|
10
Wells Fargo
WFC
$244B
| $18.5M | 3.62% |
333,869
+10,851
| +3% | +$581K |
2013 Q2
20 quarters
|
|
11
Citigroup
C
$209B
| $17.2M | 3.37% |
257,539
-4,087
| -2% | -$281K |
2013 Q2
20 quarters
|
|
12
GE Aerospace
GE
$319B
| $15.1M | 2.96% |
231,876
-4,215
| -2% | -$281K |
2013 Q2
20 quarters
|
|
13
Walmart Inc
WMT
$891B
| $13.9M | 2.72% |
487,122
-6,168
| -1% | -$175K |
2013 Q2
20 quarters
|
|
14
Procter & Gamble
PG
$355B
| $13.9M | 2.72% |
177,937
-997
| -0.6% | -$75K |
2013 Q2
20 quarters
|
|
15
Union Pacific
UNP
$168B
| $13.8M | 2.71% |
97,544
-1,575
| -2% | -$220K |
2015 Q1
13 quarters
|
|
16
Bristol-Myers Squibb
BMY
$116B
| $13.2M | 2.58% |
237,904
-1,980
| -0.8% | -$107K |
2017 Q1
5 quarters
|
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $13.1M | 2.56% |
78,429
-672
| -0.8% | -$108K |
2016 Q4
6 quarters
|
|
|
18
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.95B
| $12.4M | 2.42% |
+443,009
| New | +$12.3M |
2018 Q2
0 quarters
|
|
19
CVS Health
CVS
$112B
| $11.1M | 2.17% |
172,645
-1,979
| -1% | -$130K |
2015 Q1
13 quarters
|
|
|
20
Schwab US TIPS ETF
SCHP
$16.2B
| $10.6M | 2.07% |
+385,662
| New | +$10.5M |
2018 Q2
0 quarters
|
|
21
McKesson
MCK
$112B
| $8.88M | 1.74% |
+66,550
| New | +$9.73M |
2018 Q2
0 quarters
|
|
22
Emerson Electric
EMR
$91.2B
| $8.77M | 1.72% |
126,875
-2,809
| -2% | -$197K |
2015 Q3
11 quarters
|
|
23
Polaris
PII
$2.94B
| $8.71M | 1.71% |
71,327
-282
| -0.4% | -$33K |
2016 Q1
9 quarters
|
|
24
Qualcomm
QCOM
$189B
| $7.95M | 1.56% |
141,611
-63
| -0% | -$3.52K |
2014 Q4
14 quarters
|
|
|
25
Johnson & Johnson
JNJ
$599B
| $7.01M | 1.37% |
57,794
-2,481
| -4% | -$310K |
2013 Q2
20 quarters
|
|
Similar funds
DBC
BII
HCMNY
DK
AVAX
IVA
LCM
WEC
Horan Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Horan Capital Management held 76 positions worth $511M, up 11% from $461M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Horan Capital Management deployed $33.4M of net new capital in Q2 2018, opening 19 new positions and adding to 11 existing holdings. Its largest new stake was Amazon: 478,300 shares worth $40.7M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $5.91M trimmed.
- Horan Capital Management's largest Q2 2018 buy was Amazon: 478,300 shares worth $40.7M.
- Horan Capital Management added most to Meta Platforms (Facebook) in Q2 2018, an estimated $2.94M increase.
- Horan Capital Management's biggest Q2 2018 reduction was Cisco, cutting an estimated $5.91M.
- Horan Capital Management fully exited Pfizer in Q2 2018, selling an estimated $8.93M.
- Horan Capital Management's ten largest holdings make up 53% of its $511M portfolio in Q2 2018.
- Horan Capital Management opened 19 new positions and closed 9 in Q2 2018.
- Horan Capital Management's portfolio value rose 11% quarter-over-quarter to $511M.
Based on Horan Capital Management's 13F filing for Q2 2018, filed 27 Jul 2018.